| Product Code: ETC7853143 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Kuwait Parkinsons Disease Market Overview |
3.1 Kuwait Country Macro Economic Indicators |
3.2 Kuwait Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Kuwait Parkinsons Disease Market - Industry Life Cycle |
3.4 Kuwait Parkinsons Disease Market - Porter's Five Forces |
3.5 Kuwait Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Kuwait Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Kuwait Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Kuwait Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Kuwait Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Kuwait Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about Parkinson's disease and its diagnosis and treatment options among healthcare professionals and patients. |
4.2.2 Growing elderly population in Kuwait, as Parkinson's disease is more prevalent in older age groups. |
4.2.3 Technological advancements in healthcare, leading to improved diagnosis and treatment methods for Parkinson's disease. |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities for Parkinson's disease management in Kuwait. |
4.3.2 High treatment costs associated with Parkinson's disease medications and therapies. |
4.3.3 Lack of trained healthcare professionals specializing in Parkinson's disease care in Kuwait. |
5 Kuwait Parkinsons Disease Market Trends |
6 Kuwait Parkinsons Disease Market, By Types |
6.1 Kuwait Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Kuwait Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Kuwait Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Kuwait Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Kuwait Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Kuwait Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Kuwait Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Kuwait Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Kuwait Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Kuwait Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Kuwait Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Kuwait Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Kuwait Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Kuwait Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Kuwait Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Kuwait Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Kuwait Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Kuwait Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Kuwait Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Kuwait Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Kuwait Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Kuwait Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Kuwait Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Kuwait Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Kuwait Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Kuwait Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Kuwait Parkinsons Disease Market Export to Major Countries |
7.2 Kuwait Parkinsons Disease Market Imports from Major Countries |
8 Kuwait Parkinsons Disease Market Key Performance Indicators |
8.1 Average waiting time for Parkinson's disease diagnosis and treatment. |
8.2 Number of research studies and clinical trials focused on Parkinson's disease in Kuwait. |
8.3 Percentage of Parkinson's disease patients receiving regular follow-up care and support services. |
9 Kuwait Parkinsons Disease Market - Opportunity Assessment |
9.1 Kuwait Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Kuwait Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Kuwait Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Kuwait Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Kuwait Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Kuwait Parkinsons Disease Market - Competitive Landscape |
10.1 Kuwait Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Kuwait Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here